Skip to content

Yoga Study in Breast Cancer Patients

Effect of Yoga on Weight and Fatigue in Breast Cancer Patients Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00476203
Acronym
Yoga
Enrollment
63
Registered
2007-05-21
Start date
2007-05-31
Completion date
2011-05-31
Last updated
2012-11-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Keywords

Breast Cancer, Yoga, Quality of Life, Obesity, Fatigue, Weight

Brief summary

This purpose of this study is to test whether a 6-month yoga program improves quality of life and reduces fatigue and weight gain in breast cancer survivors.

Detailed description

Women who are overweight or obese have a higher risk of breast cancer than normal weight women. Furthermore, women who are overweight or obese or gain weight after diagnosis have an increased risk of recurrence or dying from breast cancer compared with normal weight women. Yoga has been associated with reduced weight gain and weight loss in persons without cancer. However, no studies have tested whether yoga leads to less weight gain or weight loss in breast cancer patients. Both obesity and the sequelae of breast cancer therapy can result in reduced health-related quality of life and severe fatigue, which may also be favorably affected by yoga practice. The specific aims of the proposed trial are to examine, in women with Stage 0-IIIa breast cancer who are at least 3 months post primary treatment for their disease (other than tamoxifen or aromatase inhibitors), the effects of a 6-month yoga intervention on health-related quality of life, fatigue, and body weight.

Interventions

BEHAVIORALYoga

Instructor-led yoga classes 1/time per week + 4 days of home practice

OTHERDelayed yoga classes

Delayed yoga classes (after 6 months) offered \[wait list control group\]

Sponsors

National Institutes of Health (NIH)
CollaboratorNIH
Fred Hutchinson Cancer Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
21 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Female * Age 21-75 * Diagnosed with a primary breast cancer Stage 0-IIIa * Current tamoxifen or aromatase inhibitor use is allowed * At least 3 months post treatment (e.g., surgery, chemotherapy, or radiation therapy) * BMI: 24 kg/m2 or greater (If Asian or Asian-American BMI: 23 kg/m2 or greater) * No contraindications to participating in a yoga program * Able to come for clinic visits, and attend weekly classes, and fill out questionnaires and logs in English * Gives informed consent, agrees to be randomly assigned

Exclusion criteria

* Plans to leave the study area within the follow-up period * Is pregnant or plans to become pregnant during the study period. * History of myocardial infarction (heart attack) or stroke in the previous 6 months, or diabetes (current diagnosis) * Has practiced yoga more than 1 time per month in the past six months. * Current use of medications likely to interfere with adherence to interventions or study outcomes * Alcohol or drug abuse, significant mental illness (as assessed by study staff impression)

Design outcomes

Primary

MeasureTime frame
quality of life, fatigue, and body weightbaseline, 6 months, 12 months

Secondary

MeasureTime frame
waist and hip circumferencebaseline, 6 months, 12 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026